• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

XRHealth Secures Patent to Incorporate Apple Watch into VR/AR Therapy

by Fred Pennic 09/15/2020 Leave a Comment

XRHealth Secures Patent to Incorporate Apple Watch into VR/AR Therapy

What You Should Know:

– XRHealth has just received a patent for its approach to incorporate biofeedback from devices such as an Apple watch into its remote healthcare therapy platform that utilizes virtual/artificial reality (VR/AR).

– XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical-grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat.


XRHealth, the leader in extended reality therapeutic applications, announces that they received a patent to utilize approaches that incorporate biofeedback into their extended reality therapy.  U.S. Patent No. 16/067,480, entitled “A Therapy and Physical Training Device,” was issued on September 15, 2020. 

These novel approaches enable VR/AR therapy to address patient pain based on biofeedback such us heart rate variability, EEG, galvanic skin response, and other critical responses while patients are using the VR/AR devices.  Solutions that incorporate biofeedback allow patient treatment to be customized according to their unique needs and better inform clinicians on how patients are responding to therapy.

VR/AR therapy Integration with Apple Watch

YouTube video

XRHealth plans to incorporate their VR/AR therapy with the Apple Watch, specifically since the watch has advanced features including a medical grade, FDA-cleared electrocardiogram (EKG) that measures heartbeat. XRHealth will use the output measurements of the Apple Watch to detect pain, which will modify VR/AR therapy treatment for patients based on the pain that they feel during the sessions.

“The newly awarded patent reflects XRHealth’s commitment to creating the most sophisticated form of therapy that responds to patient physical needs in real-time,” said Eran Orr, CEO of XRHealth. “Virtual Reality therapy that incorporates biofeedback will enhance and personalize the patient experience and provide clinicians with critical insights.” 

XRHealth created the first virtual reality telehealth clinic in the world that treats multiple conditions like anxiety & stress, cognitive impairment, pain management, Parkinson’s, and multiple sclerosis. XRHealth provides doctors with patient data that allows them to monitor and treat them in real-time.

Tagged With: apple, Apple Watch, Augmented Reality, FDA, Heart, Pain Management, Patient Experience, telehealth, Virtual Reality, XRHealth

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |